GLP-1 receptor agonist cessation While cessation of GLP-1 RA treatment is associated with marked weight regain, whether repeated GLP-1 RAs treatment and subsequent weight regain increases the risk for sarcopenia or sarcopenic obesity remains unknown
Cao Y, Zhao L-W, Chen Z-X, Li S-H (2024) New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimers disease
At Perfect B in Doral, FL, CJC-1295/Ipamorelin is prescribed as part of a supervised peptide protocol because the clinical difference between starting at 37 versus waiting until 52 is measurable and significant
qRT-PCR analysis was performed using the SYBR Green/Hi-ROX qRT-PCR Kit on a Rotor-Gene Q system (Qiagen, Germany)
Ke, C., Zhu, X., Zhang, Y
Adjusting medication regimens or dietary changes may be necessary for those on medications that affect B12 absorption